Mitochondrial rejuvenation after induced pluripotency.
Level 5 - mechanism / opinion, no new human data
In vitro bench research examining cell lines (mechanism-based reasoning / laboratory study).
PubMed 21124794 · doi:10.1371/journal.pone.0014095
What was done
Researchers evaluated mitochondrial characteristics across two aged fibroblast cell lines, their corresponding induced pluripotent stem cells (IPSCs), and fibroblasts re-differentiated from these IPSCs via an extensive differentiation protocol. Assessments were performed using biochemical methods and electron microscopy.
What was found
The authors reported a dramatic improvement in the quality and function of the mitochondrial complement in re-derived fibroblasts compared to the aged input fibroblasts. No specific numerical data, effect sizes, or p-values were reported in the abstract.
Why it matters
The findings indicate that IPSC reprogramming and subsequent differentiation can reverse age-related mitochondrial dysfunction in vitro, showing that reprogramming resets metabolic capacity alongside other aging markers.
Limits
The study is an in vitro experiment restricted to only two cell lines. The abstract provides no quantitative metrics or statistical values, and findings cannot be directly extrapolated to in vivo tissue aging without further testing.
Cited by
- supports Cellular reprogramming resets damaged mitochondria back to a younger, better-functioning state.